Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Establish good genomic practice to guide medicine forward.

Literature DB >> 23652098

Establish good genomic practice to guide medicine forward.

Richard W Barker¹, David A Brindley, Anna Schuh.

Abstract

Mesh：

Year: 2013 PMID： 23652098 DOI： 10.1038/nm0513-530

Source DB: PubMed Journal: Nat Med ISSN： 1078-8956 Impact factor: 53.440

× No keyword cloud information.

2 in total

1. Charting a course for genomic medicine from base pairs to bedside.

Authors: Eric D Green; Mark S Guyer
Journal: Nature Date: 2011-02-10 Impact factor: 49.962

2. Organizational challenges in clinical genomic research.

Authors: Jill S Altshuler; David Altshuler
Journal: Nature Date: 2004-05-27 Impact factor: 49.962

2 in total

6 in total

1. The implementation of novel collaborative structures for the identification and resolution of barriers to pluripotent stem cell translation.

Authors: David A Brindley; Anna French; Jane Suh; MacKenna Roberts; Benjamin Davies; Rafael Pinedo-Villanueva; Karolina Wartolowska; Kelly Rooke; Anneke Kramm; Andrew Judge; Mark Morrey; Amit Chandra; Hannah Hurley; Liam Grover; Ian Bingham; Bernard Siegel; Matt S Rattley; R Lee Buckler; David McKeon; Katie Krumholz; Lilian Hook; Michael May; Sarah Rikabi; Rosie Pigott; Megan Morys; Afsie Sabokbar; Emily Titus; Yacine Laabi; Gilles Lemaitre; Raymond Zahkia; Doug Sipp; Robert Horne; Christopher Bravery; David Williams; Ivan Wall; Evan Y Snyder; Jeffrey M Karp; Richard W Barker; Kim Bure; Andrew J Carr; Brock Reeve
Journal: Stem Cells Dev Date: 2013-12 Impact factor: 3.272

Establish good genomic practice to guide medicine forward.

1. Charting a course for genomic medicine from base pairs to bedside.

2. Organizational challenges in clinical genomic research.

1. The implementation of novel collaborative structures for the identification and resolution of barriers to pluripotent stem cell translation.

Review 2. An evaluation of regulatory and commercial barriers to stratified medicine development and adoption.

3. Characteristics associated with informed consent for genetic studies in the ACCORD trial.

Review 4. Personalized medicine in thrombosis: back to the future.

5. Development of cancer genetic services in the UK: A national consultation.

Review 6. Clinical Quality Considerations when Using Next-Generation Sequencing (NGS) in Clinical Drug Development.